Aethlon Medical
AEMD
11 hedge funds and large institutions have $684K invested in Aethlon Medical in 2017 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.
83% more funds holding
Funds holding: 6 → 11 (+5)
56% more capital invested
Capital invested by funds: $437K → $684K (+$247K)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$258K |
| 2 |
VF
Virtu Financial
New York
|
+$64.6K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$43K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$21.5K |
| 5 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$21.5K |
Top Sellers
| 1 |
DADC
D.A. Davidson & Co
Great Falls,
Montana
|
-$3K |
| 2 |
Morgan Stanley
New York
|
-$1K |
AEMD Hedge Fund Activity: Q3 2017 in Review
11 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q3 2017, worth a combined $684K — up 56% from $437K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new AEMD positions and 0 closed out — a net gain of 5 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Vanguard Group, adding an estimated $258K. The largest seller was D.A. Davidson & Co, cutting an estimated $3K.
- 11 institutional investors held Aethlon Medical (AEMD) as of Q3 2017, up from 6 in Q2 2017.
- Funds reported $684K of Aethlon Medical stock for Q3 2017, up 56% quarter-over-quarter.
- 5 funds opened new Aethlon Medical positions in Q3 2017 and 0 closed out, a net change of +5 holders.
- The largest Aethlon Medical buyer in Q3 2017 was Vanguard Group, an estimated $258K added.
- The largest Aethlon Medical seller in Q3 2017 was D.A. Davidson & Co, an estimated $3K sold.
Based on aggregated 13F filings for Q3 2017.